HDAC9 and cancer: Indeed, compounds inhibiting both HDAC and LSD1 have synergistic actions in regulating apoptosis37,38, and combined HDAC/LSD1 inhibition has been proposed as a pharmacological approach for cancers that are unresponsive to single drug therapies38.